Combination of apatinib with apo-IDO1 inhibitor for the treatment of colorectal cancer

Long‐Bo Yu(Nanjing University), Wenjie Guo(Chinese Academy of Medical Sciences & Peking Union Medical College), Jian Gao(Hebei Medical University), Shushan Ge(Soochow University), Haiqing Zhong(Nanjing University), Yingxue He(Nanjing University), Yisheng Lai(China Pharmaceutical University), Wen Liu, Qiang Xu(China Pharmaceutical University), Yuanyuan Wang(University of South China), Yi Zou(China Pharmaceutical University)
International Immunopharmacology
September 18, 2022
Cited by 9


Related Papers